During the corresponding time, Infinity Pharmaceuticals Inc saw a revenue deteriorated by -15.01 % year on year, sequentially revenue fell by -20.25 %. While revenue at the Infinity Pharmaceuticals Inc 's corporate clients
Infinity Pharmaceuticals Inc's Comment on Sales, Marketing and Customers
We currently have no marketing, commercial sales, or distribution capabilities.
We do, however, currently have worldwide commercialization rights for our PI3K-gamma
inhibitor program, including IPI-549. In order to commercialize IPI-549, if and
when it is approved for sale, we will need to, and we intend to, develop the necessary
marketing, sales and distribution capabilities.
Infinity Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers
We currently have no marketing, commercial sales, or distribution capabilities.
We do, however, currently have worldwide commercialization rights for our PI3K-gamma
inhibitor program, including IPI-549. In order to commercialize IPI-549, if and
when it is approved for sale, we will need to, and we intend to, develop the necessary
marketing, sales and distribution capabilities.
Sources:
Infinity Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Infinity Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Infinity Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.